Skip to main content

Advertisement

SpringerLink
Log in

Lymphotoxin alfa and receptor-interacting protein kinase 1 gene polymorphisms may correlate with prognosis in patients with diffuse large B cell lymphoma treated with R-CHOP

  • Original Article
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

Abstract

Purpose

Diffuse large B cell lymphoma (DLBCL) is a heterogenous disease entity due to diverse clinical outcomes to treatment. Most anticancer agents, regardless of their distinct mechanisms of action, ultimately kill cancer cells by inducing apoptosis. Accordingly, the present study analyzed the impact of polymorphisms of apoptosis-related genes on outcome in DLBCL patient treated with R-CHOP.

Patients and methods

Ninety patients with DLBCL treated with R-CHOP were enrolled in the present study. The genomic DNA was extracted from paraffin-embedded tissue and 22 polymorphisms of 18 apoptosis-related genes were assessed using a polymerase chain reaction–restriction fragment length polymorphism assay.

Results

All the evaluable patients were responsive to R-CHOP. The multivariate analysis showed that the AA genotype of lymphotoxin alpha (LTA) C804A (rs1041981) and GG genotype of RIPK1 G83A (rs2272990) were significantly correlated with a worse time to progression (TTP) compared with the combined C/A and C/C genotype and the combined G/A and A/A genotype (hazard ratio [HR] = 7.92; 95% confidence interval [CI] = 1.42–44.18; P = 0.018 and HR = 20.02; 95% CI = 1.59–251.52; P value = 0.018, respectively), whereas no association was observed between the other polymorphisms and TTP.

Conclusion

The polymorphisms of LTA (rs1041981) and RIPK1 (rs2272990) may correlate with TTP in patients with DLBCL treated with R-CHOP.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Coiffier B, Lepage E, Briere J, Herbrecht R, Tilly H, Bouabdallah R, Morel P, Van Den Neste E, Salles G, Gaulard P, Reyes F, Lederlin P, Gisselbrecht C (2002) CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B cell lymphoma. N Engl J Med 346:235–242

    Article  CAS  PubMed  Google Scholar 

  2. Feugier P, Van Hoof A, Sebban C, Solal-Celigny P, Bouabdallah R, Ferme C, Christian B, Lepage E, Tilly H, Morschhauser F, Gaulard P, Salles G, Bosly A, Gisselbrecht C, Reyes F, Coiffier B (2005) Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B cell lymphoma: a study by the Groupe d’Etude des Lymphomes de l’Adulte. J Clin Oncol 23:4117–4126

    Article  CAS  PubMed  Google Scholar 

  3. Pfreundschuh M, Trumper L, Osterborg A, Pettengell R, Trneny M, Imrie K, Ma D, Gill D, Walewski J, Zinzani PL, Stahel R, Kvaloy S, Shpilberg O, Jaeger U, Hansen M, Lehtinen T, Lopez-Guillermo A, Corrado C, Scheliga A, Milpied N, Mendila M, Rashford M, Kuhnt E, Loeffler M (2006) CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group. Lancet Oncol 7:379–391

    Article  CAS  PubMed  Google Scholar 

  4. Anderson DR, Grillo-Lopez A, Varns C, Chambers KS, Hanna N (1997) Targeted anti-cancer therapy using rituximab, a chimaeric anti-CD20 antibody (IDEC-C2B8) in the treatment of non-Hodgkin’s B cell lymphoma. Biochem Soc Trans 25:705–708

    CAS  PubMed  Google Scholar 

  5. Clynes RA, Towers TL, Presta LG, Ravetch JV (2000) Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets. Nat Med 6:443–446

    Article  CAS  PubMed  Google Scholar 

  6. Reff ME, Carner K, Chambers KS, Chinn PC, Leonard JE, Raab R, Newman RA, Hanna N, Anderson DR (1994) Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20. Blood 83:435–445

    CAS  PubMed  Google Scholar 

  7. Ellis PA, Smith IE, McCarthy K, Detre S, Salter J, Dowsett M (1997) Preoperative chemotherapy induces apoptosis in early breast cancer. Lancet 349:849

    Article  CAS  PubMed  Google Scholar 

  8. Kerr JF, Winterford CM, Harmon BV (1994) Apoptosis: its significance in cancer and cancer therapy. Cancer 73:2013–2026

    Article  CAS  PubMed  Google Scholar 

  9. Thomas M, Kalita A, Labrecque S, Pim D, Banks L, Matlashewski G (1999) Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol Cell Biol 19:1092–1100

    CAS  PubMed  Google Scholar 

  10. Dumont P, Leu JI, Della Pietra AC 3rd, George DL, Murphy M (2003) The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet 33:357–365

    Article  CAS  PubMed  Google Scholar 

  11. Rajaraman P, Wang SS, Rothman N, Brown MM, Black PM, Fine HA, Loeffler JS, Selker RG, Shapiro WR, Chanock SJ, Inskip PD (2007) Polymorphisms in apoptosis and cell cycle control genes and risk of brain tumors in adults. Cancer Epidemiol Biomarkers Prev 16:1655–1661

    Article  CAS  PubMed  Google Scholar 

  12. Kim JG, Sohn SK, Chae YS, Cho YY, Bae HI, Yan G, Park JY, Lee MH, Chung HY, Yu W (2007) Vascular endothelial growth factor gene polymorphisms associated with prognosis for patients with gastric cancer. Ann Oncol 18:1030–1036

    Article  CAS  PubMed  Google Scholar 

  13. Cheson BD, Horning SJ, Coiffier B, Shipp MA, Fisher RI, Connors JM, Lister TA, Vose J, Grillo-Lopez A, Hagenbeek A, Cabanillas F, Klippensten D, Hiddemann W, Castellino R, Harris NL, Armitage JO, Carter W, Hoppe R, Canellos GP (1999) Report of an international workshop to standardize response criteria for non-Hodgkin’s lymphomas NCI Sponsored International Working Group. J Clin Oncol 17:1244

    CAS  PubMed  Google Scholar 

  14. Schwartz PS, Waxman DJ (2001) Cyclophosphamide induces caspase 9-dependent apoptosis in 9L tumor cells. Mol Pharmacol 60:1268–1279

    CAS  PubMed  Google Scholar 

  15. Gamen S, Anel A, Perez-Galan P, Lasierra P, Johnson D, Pineiro A, Naval J (2000) Doxorubicin treatment activates a Z-VAD-sensitive caspase, which causes deltapsim loss, caspase-9 activity, and apoptosis in Jurkat cells. Exp Cell Res 258:223–235

    Article  CAS  PubMed  Google Scholar 

  16. Robertson JD, Gogvadze V, Zhivotovsky B, Orrenius S (2000) Distinct pathways for stimulation of cytochrome c release by etoposide. J Biol Chem 275:32438–32443

    Article  CAS  PubMed  Google Scholar 

  17. Zhou X, Hu W, Qin X (2008) The role of complement in the mechanism of action of rituximab for B cell lymphoma: implications for therapy. Oncologist 13:954–966

    Article  CAS  PubMed  Google Scholar 

  18. Johnstone RW, Ruefli AA, Lowe SW (2002) Apoptosis: a link between cancer genetics and chemotherapy. Cell 108:153–164

    Article  CAS  PubMed  Google Scholar 

  19. Kitada S, Pedersen IM, Schimmer AD, Reed JC (2002) Dysregulation of apoptosis genes in hematopoietic malignancies. Oncogene 21:3459–3474

    Article  CAS  PubMed  Google Scholar 

  20. Zodelava M, Datikashvili-David I (2005) Prognostic significance of apoptosis-related CD95 antigen expression in patients with non-Hodgkin’s lymphoma. Georgian Med News 3:7–9

    Google Scholar 

  21. Yasuda H, Sugimoto K, Imai H, Isobe Y, Sasaki M, Kojima Y, Nakamura S, Oshimi K (2009) Expression levels of apoptosis-related proteins and Ki-67 in nasal NK/T cell lymphoma. Eur J Haematol 82:39–45

    Article  PubMed  Google Scholar 

  22. ten Berge RL, Meijer CJ, Dukers DF, Kummer JA, Bladergroen BA, Vos W, Hack CE, Ossenkoppele GJ, Oudejans JJ (2002) Expression levels of apoptosis-related proteins predict clinical outcome in anaplastic large cell lymphoma. Blood 99:4540–4546

    Article  CAS  PubMed  Google Scholar 

  23. Sohn SK, Jung JT, Kim DH, Kim JG, Kwak EK, Park T, Shin DG, Sohn KR, Lee KB (2003) Prognostic significance of bcl-2, bax, and p53 expression in diffuse large B cell lymphoma. Am J Hematol 73:101–107

    Article  CAS  PubMed  Google Scholar 

  24. Jost PJ, Ruland J (2007) Aberrant NF-kappaB signaling in lymphoma: mechanisms, consequences, and therapeutic implications. Blood 109:2700–2707

    CAS  PubMed  Google Scholar 

  25. Karin M, Lin A (2002) NF-kB at the crossroads of life and death. Nat Immunol 3:221–227

    Article  CAS  PubMed  Google Scholar 

  26. Warzocha K, Ribeiro P, Bienvenu J, Roy P, Charlot C, Rigal D, Coiffier B, Salles G (1998) Genetic polymorphisms in the tumor necrosis factor locus influence non-Hodgkin’s lymphoma outcome. Blood 91:3574–3581

    CAS  PubMed  Google Scholar 

  27. Seidemann K, Zimmermann M, Book M, Meyer U, Burkhardt B, Welte K, Reiter A, Stanulla M (2005) Tumor necrosis factor and lymphotoxin alfa genetic polymorphisms and outcome in pediatric patients with non-Hodgkin’s lymphoma: results from Berlin–Frankfurt–Munster Trial NHL-BFM 95. J Clin Oncol 23:8414–8421

    Article  CAS  PubMed  Google Scholar 

  28. Takei K, Ikeda S, Arai T, Tanaka N, Muramatsu M, Sawabe M (2008) Lymphotoxin-alpha polymorphisms and presence of cancer in 1, 536 consecutive autopsy cases. BMC Cancer 8:235

    Article  PubMed  Google Scholar 

  29. Niwa Y, Ito H, Matsuo K, Hirose K, Ito N, Mizuno M, Hamajima N, Tajima K, Nakanishi T (2007) Lymphotoxin-alpha polymorphisms and the risk of endometrial cancer in Japanese subjects. Gynecol Oncol 104:586–590

    Article  CAS  PubMed  Google Scholar 

  30. Ozaki K, Ohnishi Y, Iida A, Sekine A, Yamada R, Tsunoda T, Sato H, Sato H, Hori M, Nakamura Y, Tanaka T (2002) Functional SNPs in the lymphotoxin-alpha gene that are associated with susceptibility to myocardial infarction. Nat Genet 32:650–654

    Article  CAS  PubMed  Google Scholar 

  31. Messer G, Spengler U, Jung MC, Honold G, Blomer K, Pape GR, Riethmuller G, Weiss EH (1991) Polymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF-beta production. J Exp Med 173:209–219

    Article  CAS  PubMed  Google Scholar 

  32. Hsu H, Huang J, Shu HB, Baichwal V, Goeddel DV (1996) TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. Immunity 4:387–396

    Article  CAS  PubMed  Google Scholar 

  33. Jagiello P, Gencik M, Arning L, Wieczorek S, Kunstmann E, Csernok E, Gross WL, Epplen JT (2004) New genomic region for Wegener’s granulomatosis as revealed by an extended association screen with 202 apoptosis-related genes. Hum Genet 114:468–477

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Oncology/Hematology, Kyungpook National University Hospital, Kyungpook National University School of Medicine, Daegu, 700-721, Korea

    Yee Soo Chae, Jong Gwang Kim, Sang Kyun Sohn, Joon Ho Moon, Shi Nae Kim & Su Jeong Lee

  2. Department of Pathology, Kyungpook National University Hospital, Kyungpook National University School of Medicine, Daegu, Korea

    Tae-In Park

  3. Technology Center for Diagnosis and Prediction, Kyungpook National University School of Medicine, Daegu, Korea

    Myung-Hoon Lee

Authors
  1. Yee Soo Chae
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jong Gwang Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sang Kyun Sohn
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Joon Ho Moon
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Shi Nae Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Su Jeong Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Tae-In Park
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Myung-Hoon Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Jong Gwang Kim or Sang Kyun Sohn.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chae, Y.S., Kim, J.G., Sohn, S.K. et al. Lymphotoxin alfa and receptor-interacting protein kinase 1 gene polymorphisms may correlate with prognosis in patients with diffuse large B cell lymphoma treated with R-CHOP. Cancer Chemother Pharmacol 65, 571–577 (2010). https://doi.org/10.1007/s00280-009-1066-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00280-009-1066-x

Keywords

Search

Navigation